Tamoxifen treatment and pulmunary embolism: a case report and literature review
AbstractBreast carcinoma is becoming a spread disease that needs a specif teraphy. Tamoxifen is the first line treatment in patients with positivity of expression of estrogen receptors. The risk of thromboembolism is high in patients treated with tamoxifene indipendent from the neoplastic disease. This work focuses the attention on tamoxifen mechanism of thrombosis.
- Abstract views: 786
- PDF: 776
Copyright (c) 2015 Gregoriana Zanini, Benedetta Fontanella, Marco Racheli, Monica Bortolotti, Gianfranco Pasini
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.